ArticleFrontiers in immunology2021

Editorial: Role of the IL-23/IL-17 Pathway in Chronic Immune-Mediated Inflammatory Diseases: Mechanisms and Targeted Therapies.

Elisabetta Bianchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.